Trial · NCT00689104
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo | 497 | |
| Overall Study | STARTED | Mirabegron 50 mg | 497 | |
| Overall Study | STARTED | Mirabegron 100 mg | 498 | |
| Overall Study | STARTED | Tolterodine SR 4 mg | 495 | |
| Overall Study | Safety Analysis Set (SAF) | Placebo | 494 | |
| Overall Study | Safety Analysis Set (SAF) | Mirabegron 50 mg | 493 | |
| Overall Study | Safety Analysis Set (SAF) | Mirabegron 100 mg | 496 | |
| Overall Study | Safety Analysis Set (SAF) | Tolterodine SR 4 mg | 495 | |
| Overall Study | Full Analysis Set (FAS) | Placebo | 480 | |
| Overall Study | Full Analysis Set (FAS) | Mirabegron 50 mg | 473 | |
| Overall Study | Full Analysis Set (FAS) | Mirabegron 100 mg | 478 | |
| Overall Study | Full Analysis Set (FAS) | Tolterodine SR 4 mg | 475 | |
| Overall Study | Full Analysis Set Incontinence (FAS-I) | Placebo | 291 | |
| Overall Study | Full Analysis Set Incontinence (FAS-I) | Mirabegron 50 mg | 293 | |
| Overall Study | Full Analysis Set Incontinence (FAS-I) | Mirabegron 100 mg | 281 | |
| Overall Study | Full Analysis Set Incontinence (FAS-I) | Tolterodine SR 4 mg | 300 | |
| Overall Study | COMPLETED | Placebo | 453 | |
| Overall Study | COMPLETED | Mirabegron 50 mg | 440 | |
| Overall Study | COMPLETED | Mirabegron 100 mg | 453 | |
| Overall Study | COMPLETED | Tolterodine SR 4 mg | 445 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00689104/flow